Ifp Advisors, Inc Y M Abs Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$3.0 - $15.17 $309 - $1,562	103 New	103 $2,000
Q3 2021 Oct 06, 2021	SELL	$27.47 - $37.31 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$25.45 - $37.64 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$29.16 - $51.96 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$37.86 - $54.26 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$35.13 - $43.62 $0 - $0	0 New	0 $0

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $356M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.